AF
ABVX

Avanza Fonder’s Abivax ABVX Stock Holding History

Avanza Fonder’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,249
Closed -$168K – 485
2025
Q4 		$168K Buy
+1,249
New +$136K ﹤0.01% 435

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Avanza Fonder's ABVX Position: Q1 2026 in Review

Avanza Fonder sold out of Abivax (ABVX) in Q1 2026, closing a stake of 1,249 shares — an estimated $168K sold.

Avanza Fonder first reported a position in ABVX in Q4 2025 and held it in 1 quarter. The position peaked at $168K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Avanza Fonder reported no remaining Abivax position as of Q1 2026 after selling out during the quarter.
  • Avanza Fonder sold 1,249 Abivax shares in Q1 2026, an estimated $168K.
  • Avanza Fonder first reported a position in Abivax in Q4 2025 and held it in 1 quarter.
  • Avanza Fonder's Abivax position peaked at $168K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Avanza Fonder's 13F filing for Q1 2026, filed 15 Apr 2026.